Entries by

BioGX Launches Four CE-Marked IVD Assays At The European Congress Of Clinical Microbiology And Infectious Diseases (ECCMID)

VIENNA, AUSTRIA, April 24, 2017 /PRNewswire/ — BioGX, a Birmingham Alabama based molecular diagnostics company, announced the launch of four additional CE-IVD infectious disease tests at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), reflecting the inspiring vision of ECCMID: “Managing Infections, Promoting Science”. BioGX has developed an extensive line of multiplex tests […]

Announcing The Establishment Of BioGX EU

BIRMINGHAM, Ala., April 21, 2017 /PRNewswire/ — BioGX, a developer and manufacturer of molecular diagnostics CE-IVD tests has announced the establishment of European operations based in Amsterdam, Netherlands.

BioGX EcLiSa Test Featured By UNC

The BioGX EcLiSa test is used for testing fresh produce for contaminating bacteria like E. coli, Salmonella, and Listeria. Our work with the University of North Carolina at Chapel Hill has recently been featured in a spotlight article and video titled, “Science for safer food”. CLICK HERE to link to the article.

ARUP GI Presentation

ASM/Microbe 2016: ARUP presents a pivotal poster on assays for Molecular testing of gastrointestinal (GI) pathogens causing acute diarrhea using of BioGX’s Sample Ready technology.

ASM/Microbe 2016: Tampa General

ASM/Microbe 2016: Tampa General presents excellent analytical data on BioGX’s Sample Ready multiplex Flu A, Flu B and RSV on a BD MAXTM open channel assay platform.

ARUP Unique Study

ASM/Microbe 2016: ARUP presents a unique study on the detection of enteropathogenic Microsporidia with a multiplex real-time using of BioGX’s Sample Ready assay platform.

BioGX Achieves ISO 13485:2003 Certification

BioGX now holds a Certificate of Registration for Quality Management System (QMS)- ISO 13485;2003 (Certificate No FM 642714) and now operates a QMS which complies with the requirements of ISO 13485;2003 for “the design, development, manufacture and distribution of in-vitro diagnostics and contract specified reagents for molecular diagnostics.